Journal
/
/
在FDA批准的Vero细胞疫苗开发产生重组沙粒
JoVE Journal
Immunology and Infection
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Immunology and Infection
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
DOI:

10:03 min

August 01, 2013

, , ,

Chapters

  • 00:05Title
  • 01:36Arenavirus Rescue Transfection
  • 04:41Confirmation of Recombinant Arenavirus Rescue
  • 07:11r3LCMV and r3Candid#1 Viral Rescue
  • 08:06Results: Arenavirus in Vero Cells
  • 09:30Conclusion

Summary

Automatic Translation

救援重组砂粒病毒克隆的cDNA,称为反向遗传学的方法,使研究人员能够调查特定的病毒基因产物的作用,以及其不同的具体领域和残留物的贡献,砂粒病毒的生物学的许多不同方面。同样,反向遗传学技术在FDA批准的细胞系(Vero)疫苗研制的新一代安全有效的疫苗,打击人类致病的砂粒病毒提供了新的可能性。

Related Videos

Read Article